| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $31.2M | +93.1% |
| SG&A Expense | $13.9M | -25.6% |
| Operating Income | -$45.1M | -13.2% |
| Interest Expense | $3.8M | +23.0% |
| Net Income | -$44.6M | -5.3% |
| EPS (Basic) | -$10.31 | -1.6% |
| EPS (Diluted) | -$10.31 | -1.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.7M | -19.3% |
| Short-term Investments | $7.2M | -83.0% |
| Current Assets | $23.5M | -60.9% |
| Total Assets | $28.3M | -57.4% |
| Current Liabilities | $31.9M | +152.3% |
| Long-term Debt | $17.9M | -17.1% |
| Total Liabilities | $35.2M | +5.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.1M | +3.8% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $35.6M | +18.5% |
| Financing Cash Flow | -$2.8M | -428.6% |
| Free Cash Flow | -$36.1M | +3.9% |
| Stockholders' Equity |
| -$6.9M |
| -120.9% |